CHAPEL HILL, N.C. -- Researchers at the University of North Carolina Lineberger Comprehensive Cancer Center and University of Wisconsin-Madison say they’ve “demonstrated improved methods of capturing free-floating cancer cells that are cast-off from tumors, and circulating in the blood”.  

Doctors say these “cast-off cells” can be properly and accurately counted, and could then provide an extra way to screen and also track treatment for the disease.

UNC Lineberger’s Andrew Wang, MD, associate professor in the UNC School of Medicine Department of Radiation Oncology, sat down with Spectrum News anchor Caroline Blair to explain his research, and what this could mean for the future of cancer tracking and treatment.  

For their full report, visit UNC Health Care and UNC School of Medicine’s website.